{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:25:26Z","timestamp":1791267926913,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T00:00:00Z","timestamp":1337040000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"DOI":"10.1371\/journal.pmed.1001217","type":"journal-article","created":{"date-parts":[[2012,5,15]],"date-time":"2012-05-15T21:08:55Z","timestamp":1337116135000},"page":"e1001217","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":120,"title":["Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial"],"prefix":"10.1371","volume":"9","clinical-trial-number":[{"clinical-trial-number":"isrctn13968779","registry":"10.18810\/isrctn"}],"author":[{"given":"Diana M.","family":"Gibb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilda","family":"Kizito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth C.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ennie","family":"Chidziva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Zalwango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Nalumenya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moira","family":"Spyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinah","family":"Tumukunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kusum","family":"Nathoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Munderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hope","family":"Kyomugisha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Grosskurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Gilks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillipa","family":"Musoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the DART trial team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,5,15]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1473-3099(10)70288-7","article-title":"Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.","volume":"11","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1056\/NEJMoa0907736","article-title":"Antiretroviral regimens in pregnancy and breast-feeding in Botswana.","volume":"362","author":"RL Shapiro","year":"2010","journal-title":"N Engl J Med"},{"key":"ref3","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents: Recommendations for a public health approach. 2010 revision","year":"2010"},{"key":"ref4","article-title":"Towards universal access: scaling up priority HIV\/AIDS interventions in the health sector: progress report 2010.","year":"2010"},{"key":"ref5","article-title":"Towards universal access: scaling up priority HIV\/AIDS interventions in the health sector: progress report 2011.","year":"2011"},{"key":"ref6","article-title":"Pivotal study finds that HIV medications are highly effective as prophylaxis against HIV infection in men and women in Africa","year":"2011"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1056\/NEJMoa1011205","article-title":"Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.","volume":"363","author":"RM Grant","year":"2010","journal-title":"N Engl J Med"},{"key":"ref8","article-title":"Interim Report 1 January 1989 through 31 January 2011.","year":"2011"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1468-1293.2009.00709.x","article-title":"Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?","volume":"10","author":"C Foster","year":"2009","journal-title":"HIV Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","article-title":"PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial.","volume":"376","author":"S McCormack","year":"2010","journal-title":"Lancet"},{"key":"ref11","article-title":"Pregnancy rates & outcomes among women on triple-drug antiretroviral therapy in the DART trial [Abstract WEPEB261].","author":"P Munderi","year":"2009"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"e1000229","DOI":"10.1371\/journal.pmed.1000229","article-title":"Impact of antiretroviral therapy on incidence of pregnancy among HIV-infected women in Sub-Saharan Africa: a cohort study.","volume":"7","author":"L Myer","year":"2010","journal-title":"PLoS Med"},{"key":"ref13","article-title":"Total fertility rate.","year":"2008"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","article-title":"Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"ref15","article-title":"Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access. Recommendations for a public health approach","year":"2006"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-3156.2007.01973.x","article-title":"Twenty-four-week safety and tolerability of nevirapine vs. abacavir in combination with zidovudine\/lamivudine as first-line antiretroviral therapy: a randomized double-blind trial (NORA).","volume":"13","year":"2008","journal-title":"Trop Med Int Health"},{"key":"ref17","article-title":"Bayley scales of infant development. 2nd edition","author":"N Bayley","year":"1993"},{"key":"ref18","article-title":"Table for the grading of the severity of adult and pediatric adverse events (December 2004).","year":"2004"},{"key":"ref19","article-title":"Pediatric toxicity tables (November 2007).","year":"2007"},{"key":"ref20","article-title":"Growth velocity based on weight, length, and head circumference: methods and development","year":"2009"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1080\/03014469700005322","article-title":"Weight, height and arm circumference of children under 5 in the district of Mbarara, south-west Uganda.","volume":"24","author":"I Cortinovis","year":"1997","journal-title":"Ann Hum Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/QAI.0b013e3181c6c65c","article-title":"Early clinical and programmatic outcomes with tenofovir-based antiretroviral therapy in Zambia.","volume":"54","author":"BH Chi","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref23","article-title":"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services","year":"2011"},{"key":"ref24","article-title":"Guidelines for clinical management and treatment of HIV-infected adults in Europe. Version 6.","year":"2011"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1 infection with early antiretroviral therapy.","volume":"365","author":"MS Cohen","year":"2011","journal-title":"N Eng J Med"},{"key":"ref26","article-title":"Results of FEM-PrEP clinical trial examining pre-exposure prophylaxis (PrEP) for HIV prevention among heterosexual women","year":"2011"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/QAI.0b013e318050d683","article-title":"Pregnancy rates and birth outcomes among women on efavirenz-containing highly active antiretroviral therapy in Botswana.","volume":"45","author":"H Bussmann","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/QAI.0b013e31815c71f7","article-title":"The value of site preparedness studies for future implementation of phase 2\/IIb\/III HIV prevention trials: experience from the HPTN 055 study.","volume":"47","author":"G Ramjee","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00514-10","article-title":"Breast milk concentrations of tenofovir and emtricitabine in HIV-1 infected women in Abidjan TEmAA Step 2 (ANRS 12109).","volume":"55","author":"S Benaboud","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/clpt.2008.201","article-title":"Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109).","volume":"85","author":"D Hirt","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/AAC.48.5.1469-1487.2004","article-title":"Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques.","volume":"48","author":"KK Van Rompay","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.00350-08","article-title":"Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects.","volume":"52","author":"KK Van Rompay","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00042560-200203010-00001","article-title":"Fetal and maternal outcome after administration of tenofovir to gravid rhesus monkeys (Macaca mulatta).","volume":"29","author":"AF Tarantal","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref34","first-page":"65","article-title":"Metropolitan Atlanta Congenital Defects Program 40th Anniversary Edition Surveillance Report: Reporting birth defects surveillance data 1968\u20132003.","volume":"79","author":"A Correa","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1097\/QAD.0b013e328133884b","article-title":"Antiretroviral therapy and premature delivery in diagnosed HIV-infected women in the United Kingdom and Ireland.","volume":"21","author":"CL Townsend","year":"2007","journal-title":"AIDS"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/QAD.0b013e32802ef2f6","article-title":"Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.","volume":"21","author":"AP Kourtis","year":"2007","journal-title":"AIDS"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1471-0528.2010.02689.x","article-title":"Antiretroviral therapy and preterm delivery-a pooled analysis of data from the United States and Europe.","volume":"117","author":"C Townsend","year":"2010","journal-title":"BJOG"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jpeds.2007.12.020","article-title":"Decreased bone mineral density with off-label use of tenofovir in children and adolescents infected with human immunodeficiency virus.","volume":"152","author":"JB Purdy","year":"2008","journal-title":"J Pediatr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/QAD.0b013e328340fdca","article-title":"Prospective study of renal function in HIV-infected pediatric patients receiving tenofovir-containing HAART regimens.","volume":"25","author":"P Soler-Palacin","year":"2011","journal-title":"AIDS"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e3283333680","article-title":"Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.","volume":"24","author":"A Judd","year":"2010","journal-title":"AIDS"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/INF.0b013e31818c8d2c","article-title":"Tenofovir use in human immunodeficiency virus-1-infected children in the United kingdom and Ireland.","volume":"28","author":"A Riordan","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00198-007-0524-8","article-title":"Risk factors for decreased bone density and effects of HIV on bone in the elderly.","volume":"19","author":"S Jones","year":"2008","journal-title":"Osteoporos Int"},{"key":"ref43","article-title":"Fracture risk in HIV and the need for guidelines: the Probono-1 trial [Abstract P099].","author":"B Peters","year":"2010"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","article-title":"Continuous antiretroviral therapy decreases bone mineral density.","volume":"23","author":"B Grund","year":"2009","journal-title":"AIDS"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1097\/QAD.0b013e328340a28d","article-title":"High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study.","volume":"24","author":"A Bonjoch","year":"2010","journal-title":"AIDS"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study.","volume":"51","author":"HJ Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-2525","article-title":"Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children.","volume":"118","author":"RI Gafni","year":"2006","journal-title":"Pediatrics"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3851\/IMP1650","article-title":"Tenofovir disoproxil fumarate and bone mineral density: a 60-month longitudinal study in a cohort of HIV-infected youths.","volume":"15","author":"A Vigano","year":"2010","journal-title":"Antivir Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1345\/aph.1L083","article-title":"Adverse effects of tenofovir use in HIV-infected pregnant women and their infants.","volume":"42","author":"D Nurutdinova","year":"2008","journal-title":"Ann Pharmacother"},{"key":"ref50","article-title":"Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.","author":"GK Siberry","year":"2012","journal-title":"AIDS"},{"key":"ref51","article-title":"Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States.","year":"2010"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/QAI.0b013e3181ffa4f5","article-title":"Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.","volume":"56","author":"KM Powis","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref53","article-title":"Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. Recommendations for a public health approach (2006 version)","year":"2006"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e3877","DOI":"10.1371\/journal.pone.0003877","article-title":"Survival of infants born to HIV-positive mothers, by feeding modality, in Rakai, Uganda.","volume":"3","author":"J Kagaayi","year":"2008","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1086\/649886","article-title":"Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-infected mothers.","volume":"50","author":"L Kuhn","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/QAI.0b013e3181bdf676","article-title":"Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006.","volume":"53","author":"TL Creek","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref57","article-title":"Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: towards universal access. Recommendations for a public health approach (2010 version)","year":"2010"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1016\/S0140-6736(10)60703-9","article-title":"Neonatal, postneonatal, childhood, and under-5 mortality for 187 countries, 1970\u20132010: a systematic analysis of progress towards Millennium Development Goal 4.","volume":"375","author":"JK Rajaratnam","year":"2010","journal-title":"Lancet"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(05)67481-8","article-title":"Increased risk of incident HIV during pregnancy in Rakai, Uganda: a prospective study.","volume":"366","author":"RH Gray","year":"2005","journal-title":"Lancet"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/QAD.0b013e32832a5934","article-title":"High HIV incidence during pregnancy: compelling reason for repeat HIV testing.","volume":"23","author":"D Moodley","year":"2009","journal-title":"AIDS"}],"container-title":["PLoS Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pmed.1001217","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T16:11:47Z","timestamp":1713975107000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1001217"}},"subtitle":[],"editor":[{"given":"Landon","family":"Myer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,5,15]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1001217","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,15]]}}}